Analysis and presentation. Clinical trials on prostate cancer

Area of Science:

• Oncology
• Biostatistics
• Clinical Trial Design

Background:

• Effective analysis and presentation of clinical trial data are crucial for advancing prostate cancer research.
• Existing literature and expert experience highlight inconsistencies in reporting and statistical methods.
• Standardized guidelines are needed to improve the quality and interpretability of prostate cancer clinical trial results.

Purpose of the Study:

• To establish comprehensive guidelines for the analysis and presentation of clinical trials specifically focused on prostate cancer.
• To offer practical recommendations for researchers, clinicians, and journal editors involved in prostate cancer studies.
• To promote best practices in statistical methodology and data reporting for enhanced scientific rigor.

Main Methods:

• A systematic review of statistical and oncology textbooks and relevant articles was conducted.
• Expert clinical experience and previously published advice were synthesized.
• Key elements for trial sections (Introduction, Methods, Results, Discussion, Summary) were identified and refined.

Main Results:

• Guidelines cover essential components: primary question, trial design, patient population, disease characterization, treatment details, and toxicity.
• Emphasis is placed on appropriate statistical methods, data maturity, avoiding publication bias, and accurate interpretation of survival analysis.
• Recommendations include shifting from P-values to confidence intervals, abandoning responder-based survival comparisons, and providing data in both absolute and graphic formats.

Conclusions:

• Adherence to these guidelines will improve the analysis, presentation, and interpretation of prostate cancer clinical trials.
• Compliance facilitates direct comparisons between studies and integration into meta-analyses.
• These recommendations aim to enhance the overall quality and impact of prostate cancer research findings.